Trial Profile
Pharmacology of Rapid-acting Insulin Injected by Needle-free Jet-injection in Patients With Diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 03 Oct 2011 Actual initiation date (September 2011) added as reported by ClinicalTrials.gov.
- 03 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.